ATF3 and hepatocellular carcinoma: To further corroborate the impact of mTORC1 as the main signaling pathway in ATF3-mediated suppression of lipid biosynthesis, we treated ATF3-kd HCC cell lines with rapamycin, an inhibitor of mTORC1 [36].